- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 35/38 - EstomacIntestinCellules caliciformesMuqueuse oraleSalive
Détention brevets de la classe A61K 35/38
Brevets de cette classe: 408
Historique des publications depuis 10 ans
|
33
|
38
|
33
|
31
|
37
|
29
|
19
|
37
|
23
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Ferring Microbiome Inc. | 43 |
26 |
| Elutia Med LLC | 40 |
22 |
| Elutia Inc. | 37 |
20 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3299 |
18 |
| Crestovo Holdings LLC | 19 |
12 |
| RegenLab USA LLC | 78 |
11 |
| Cook Biotech Incorporated | 192 |
10 |
| AlloSource | 164 |
7 |
| Scarcell Therapeutics | 15 |
7 |
| Yeda Research and Development Co. Ltd. | 1376 |
7 |
| Emanate Biomedical Inc. | 31 |
7 |
| Curileum Discovery Ltd | 11 |
7 |
| ACell, Inc. | 68 |
6 |
| Korea Research Institute of Bioscience and Biotechnology | 1065 |
6 |
| Corvivo Cardiovascular, Inc. | 97 |
6 |
| InCube Labs, LLC | 165 |
5 |
| Minovia Therapeutics Ltd. | 51 |
5 |
| Ramot at Tel-Aviv University Ltd. | 1542 |
5 |
| Regents of the University of Minnesota | 2785 |
5 |
| Children's Hospital Medical Center | 746 |
4 |
| Autres propriétaires | 212 |